A retrospective review of 2019 renal allograft recipients has been performed. Risk factors, medical complications, patient and graft survival were analyzed. After a mean follow up period of 8.8 ± 5.8 years, 450 (22.2%) recipients developed NODAT. A 455 post transplantation time matched control recipients without DM was selected. NODAT does not statistically affect the graft survival. But, NODAT is a major problem endangers the patient life and must be minded to consider such patient as especially at higher risk for diabetic complications.
Nagib AM, Refaie AF, Akl AI, Neamatalla AH, Fouda MA, et al. (2015) New Onset Diabetes Mellitus after Living Donor Renal Transplantation: A Unique Pattern in the Egyptian Population. J Diabetes Metab 6:519.